HO
HOYA Corporation
HOCPF · OTC
$144.26 +0.00% (+$0.00)
1M -5.71%
Market Cap ¥7.64T
P/E Ratio 28.52x
Div. Yield 1.33%
ROE 26.23%
Bulios Fair Price
$114.87
20.4% downside
Current Price
$144.26
Undervalued Fair Value Overvalued
According to Bulios Fair Price, HOCPF is currently overvalued relative to its market price. How does it work?
Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Piotroski F-Score Moderate
6/9Valuation
28 /100
Expensive EV/EBITDA 18.50x
P/S 7.74x
P/B 7.58x
Growth
59 /100
Stable Rev. growth 10.22%
FCF growth 5.11%
Book val. growth 6.61%
Profitability
100 /100
Strong Net margin 27.15%
Op. margin 30.17%
FCF margin 24.02%
Quality
95 /100
Excellent ROE 26.23%
ROA 20.72%
Asset turnover 0.76x
Debt
100 /100
Low Current ratio 4.91x
Int. coverage 172.41x
Net debt/EBITDA -1.31x
Stability
100 /100
Stable Rev. volatility 1.32%
EPS volatility 3.79%
Profitable years 6
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Ask StockBot about HOCPF
Online
Sector
Healthcare
Industry
Medical - Instruments & Supplies
CEO
Eiichiro Ikeda
Employees
37,752
Headquarters
Tokyo
Upcoming events
29 SEP
Ex-Dividend
Ex-dividend date
29 SEP
Dividend Payment
Payment date
29 OCT
Earnings
Upcoming earnings report